Patient demographics
ONCOLOGY
Median age of patients ranged from 56.0 years (range: 50–68) in Cohort F1 to 73.5 years (range: 57–86) in Cohort A (Patient characteristics.ASCT, autologous stem cell transplant; Atezo, atezolizumab; Dara, daratumumab; Dex, dexamethasone; ECOG PS, Eastern Cooperative Oncology Group Performance Status; IMiD, immunomodulatory drug; Len, lenalidomide; PI, proteasome inhibitor; Pom, pomalidomide.*Cohort A: Atezo monotherapy; B1: Atezo+Len; C: Atezo+Len; D1/D2/D3: Atezo+Dara; E1: Atezo+Dara+Len; F1/F2: Atezo+Dara+Pom; F3: Dara+Pom+Dex
